Human Papillomavirus Vaccine Introduction – The First Five Years
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007) · PsycEXTRA Dataset · doi:10.1037/e601292007-001 · Cited by 1,882
Self-citationLe, M. (2007) · Medical Entomology and Zoology · Cited by 1,624
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
Palefsky, J. M., Giuliano, A. R., Goldstone, S., Moreira, E. D., Aranda, C., Jessen, H., Hillman, R., Ferris, D., Coutlee, F., Stoler, M. H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010971 · Cited by 948
Brotherton, J. M., Fridman, M., May, C. L., Chappell, G., Saville, A. M., & Gertig, D. M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60551-5 · Cited by 598
Self-citationPostlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine
Slade, B. A. (2009) · JAMA · doi:10.1001/jama.2009.1201 · Cited by 470
Donovan, B., Franklin, N., Guy, R., Grulich, A. E., Regan, D. G., Ali, H., Wand, H., & Fairley, C. K. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70225-5 · Cited by 380
Adverse Effects of Vaccines: Evidence and Causality
Stratton, K. R., Ford, A. Q., Rusch, E., & Clayton, E. W. (2013) · Cited by 348
Kreimer, A. R., Rodriguez, A. C., Hildesheim, A., Herrero, R., Porras, C., Schiffman, M., González, P., Solomon, D., Jiménez, S., Schiller, J. T., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr319 · Cited by 324
Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme
Binagwaho, A., Wagner, C., Gatera, M., Karema, C., Nutt, C., & Ngaboa, F. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.11.097253 · Cited by 275
LaMontagne, D. S., Barge, S., Le, N. T., Mugisha, E., Penny, M., Gandhi, S., Janmohamed, A., Kumakech, E., Mosqueira, N. R., Nguyen, N. Q., et al. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.08986 · Cited by 271
Caskey, R., Lindau, S. T., & Alexander, G. C. (2009) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2009.04.021 · Cited by 270
Brewer, N. T., Gottlieb, S. L., Reiter, P. L., McRee, A.-L., Liddon, N., Markowitz, L., & Smith, J. S. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181f12dbf · Cited by 254
Self-citationOgilvie, G., Anderson, M., Marra, F., McNeil, S., Pielak, K., Dawar, M., McIvor, M., Ehlen, T., Dobson, S., Money, D., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000270 · Cited by 229
Gee, J., Naleway, A., Shui, I., Baggs, J., Yin, R., Li, R., Kulldorff, M., Lewis, E., Fireman, B., Daley, M. F., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.106 · Cited by 227
Human Papillomavirus Vaccination Series Initiation and Completion, 2008–2009
Dorell, C. G., Yankey, D., Santibanez, T. A., & Markowitz, L. E. (2011) · Pediatrics · doi:10.1542/peds.2011-0950 · Cited by 217
Self-citationParental Decision Making about the HPV Vaccine
Allen, J. D., Othus, M. K. D., Shelton, R. C., Li, Y., Norman, N., Tom, L., & del Carmen, M. G. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0217 · Cited by 203
Dempsey, A. F., Abraham, L. M., Dalton, V., & Ruffin, M. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2009.03.011 · Cited by 200
The Ethics and Politics of Compulsory HPV Vaccination
Colgrove, J. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068248 · Cited by 200
Chao, C., Klein, N. P., Velicer, C. M., Sy, L. S., Slezak, J. M., Takhar, H., Ackerson, B., Cheetham, T. C., Hansen, J., Deosaransingh, K., et al. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02467.x · Cited by 199
Politics, Parents, and Prophylaxis — Mandating HPV Vaccination in the United States
Charo, R. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078054 · Cited by 167
Kahn, J. A., Ding, L., Huang, B., Zimet, G. D., Rosenthal, S. L., & Frazier, A. L. (2009) · PEDIATRICS · doi:10.1542/peds.2008-1536 · Cited by 138
Dorléans, F., Giambi, C., Demattè, L., Cotter, S. M., Stefanoff, P., Mereckiene, J., O’Flanagan, D., Lopalco, P. L., D’Ancona, F. “., Lévy-Bruhl, D., et al. (2010) · Eurosurveillance · doi:10.2807/ese.15.47.19730-en · Cited by 105
Post-licensure monitoring of HPV vaccine in the United States
Markowitz, L. E., Hariri, S., Unger, E. R., Saraiya, M., Datta, S., & Dunne, E. F. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.019 · Cited by 101
Self-citationUpdate on Human Papillomavirus (HPV) Vaccines
Dawar, M., Harris, T., & McNeil, S. (2012) · Canada Communicable Disease Report · doi:10.14745/ccdr.v38i00a01 · Cited by 97
Poljak, M., Seme, K., Maver, P. J., Kocjan, B. J., Cuschieri, K. S., Ивановна, Р. С., Arbyn, M., & Syrjänen, S. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.03.029 · Cited by 90
Implementation of Human Papillomavirus Immunization in the Developing World
Kane, M., Serrano, B., de Sanjosé, S., & Wittet, S. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.075 · Cited by 87
Human Papillomavirus Vaccine Initiation in an Area with Elevated Rates of Cervical Cancer
Gottlieb, S. L., Brewer, N. T., Sternberg, M., Smith, J. S., Ziarnowski, K. L., Liddon, N. C., & Markowitz, L. E. (2009) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2009.03.029 · Cited by 86
Self-citationPregnancy Outcomes From the Pregnancy Registry of a Human Papillomavirus Type6/11/16/18 Vaccine
Dana, A., Buchanan, K. M., Goss, M. A., Seminack, M. M., Shields, K. E., Korn, S., Cunningham, M. L., & Haupt, R. M. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181c2a122 · Cited by 84
Watson, M., Shaw, D. D., Molchanoff, L., & McInnes, C. (2009) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2009.00409.x · Cited by 83
Neuzil, K. M., Canh, D. G., Thiểm, V. Đ., Janmohamed, A., Vu, M. H., Tang, Y., Diệp, N. T. N., Tsu, V., & LaMontagne, D. S. (2011) · JAMA · doi:10.1001/jama.2011.407 · Cited by 82
Self-citationLehtinen, M., Apter, D. L., Dubin, G. O., Kosunen, E., Isaksson, R., Korpivaara, E.-L., Kyhä-Österlund, L., Lunnas, T., Luostarinen, T., Niemi, L., et al. (2006) · International Journal of STD & AIDS · doi:10.1258/095646206778145550 · Cited by 80
HPV vaccination in France: Uptake, costs and issues for the National Health Insurance
Fagot, J., Boutrelle, A., Ricordeau, P., Weill, A., & Allemand, H. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.064 · Cited by 79
Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far
Αγοραστός, Θ., Chatzigeorgiou, K., Brotherton, J. M. L., & Garland, S. M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.097 · Cited by 78
Self-citationHuman papillomavirus (HPV) vaccine policy and evidence-based medicine: Are they at odds?
Tomljenovic, L., & Shaw, C. A. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.645353 · Cited by 76
A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD®
Bonanni, P., Cohet, C., Kjær, S. K., Latham, N. B., Lambert, P., Reisinger, K. S., & Haupt, R. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.070 · Cited by 61
Brotherton, J. M. L., Gertig, D. M., Chappell, G., Rowlands, L., & Saville, M. (2011) · Communicable Diseases Intelligence · doi:10.33321/cdi.2011.35.18 · Cited by 57
Self-citationIntroduction of human papillomavirus vaccination in Nordic countries
Sander, B. B., Rebolj, M., Valentiner‐Branth, P., & Lynge, E. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.11.097 · Cited by 53
The LYSISTRATA Study Group, Sotiriadis, A., Dagklis, T., Siamanta, V., Chatzigeorgiou, K., & Αγοραστός, Θ. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2208-z · Cited by 51
Mello, M. M., Abiola, S. E., & Colgrove, J. K. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300576 · Cited by 49
Zimmerman, R. K., Nowalk, M. P., Lin, C. J., Fox, D. E., Ko, F.-S., Wettick, E., Cost, G., Hand, L., Hayes, J., & Michaels, M. G. (2010) · Journal of Women s Health · doi:10.1089/jwh.2009.1753 · Cited by 41
Klooster, T. M. S. ’., Kemmeren, J. M., van der Maas, N., & de Melker, H. E. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.04.050 · Cited by 31
Parental Support for the Human Papillomavirus Vaccine
Bernat, D. H., Harpin, S. B., Eisenberg, M. E., Bearinger, L. H., & Resnick, M. D. (2009) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2009.04.014 · Cited by 28
Mise à jour sur les vaccins contre le virus du papillome humain (VPH)
(CCNI), C. C. N. D. L. (2012) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v38i00a01f · Cited by 5
Cited by
Bruni, L., Diaz, M., Barrionuevo-Rosas, L., Herrero, R., Bray, F., Bosch, F. X., de Sanjosé, S., & Castellsagué, X. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30099-7 · Cited by 824
A review of clinical trials of human papillomavirus prophylactic vaccines
Schiller, J. T., Castellsagué, X., & Garland, S. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.108 · Cited by 747
Drolet, M., Bénard, É., Boily, M.-C., Ali, H., Baandrup, L., Bauer, H., Beddows, S., Brisson, J., Brotherton, J. M. L., Cummings, T., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71073-4 · Cited by 642
Self-citationVu, M., Yu, J., Awolude, O. A., & Chuang, L. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.06.003 · Cited by 548
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
Bosch, F. X., Broker, T. R., Forman, D., Moscicki, A.-B., Gillison, M. L., Doorbar, J., Stern, P. L., Stanley, M., Arbyn, M., Poljak, M., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.026 · Cited by 433
Self-citation
Metadata
- Authors
- Markowitz, L. E., Tsu, V., Deeks, S. L., Cubie, H., Wang, S. A., Vicari, A. S., & Brotherton, J. M. L.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 30
- Pages
- F139-F148
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W1997780854
- Cited by
- 364
- References
- 45
- FWCI
- 29.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.